Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

sanofi_regeneron

Sanofi/Regeneron new asthma data bolstered by potential indications

September 13, 2017
Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …

News
23andme

23andMe raises $250m in financing, research points towards its future

September 13, 2017
Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …

News

Recipharm and CTC launch integrated first in human service

September 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

News
Press release
virus-1812092_960_720

Newly adopted flu vaccine could save 1,700 lives

September 12, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …

News

Teva announces sale of Paragard for $1.1 billion

September 12, 2017
Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …

News

Questions raised after two deaths in AbbVie arthritis study

September 12, 2017
Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …

News
lonely-1822414_960_720

Mental health crisis as UK struggles with number of psychiatrists

September 11, 2017
Business Services, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical, psychiatry

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …

News
novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

News
29863293981_33b910b458_z

Teva finally announces successful CEO appointment

September 11, 2017
Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

News
casebia_logo1_rgb

Casebia Therapeutics bolsters leadership by bringing in two new faces

September 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …

Appointment
toothbrush

Aspirin may be a cost-effective alternative to fillings

September 8, 2017
Medical Communications, Research and Development aspirin, biotech, dentist, drugs, pharma, pharmaceutical, tooth decay

Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay. In …

News
bms

BMS’ Opdivo gets a potential first-line boost in kidney cancer

September 8, 2017
Medical Communications, Research and Development Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …

News
1280px-niagara_river

Antidepressants polluting rivers building up in brains of fish

September 7, 2017
Medical Communications antidepressants, biotech, drugs, pharma, pharmaceutical

A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. …

News
tom-graney_portrait

Vertex Pharma bring in new CFO, shares rise

September 7, 2017
Ironwood Pharmaceuticals, Vertex pharmaceuticals, biotech, drugs, pharma, pharmaceutical

Vertex Pharmaceuticals announced the appointment of J&J veteran, Tom Graney, as Senior Vice President and Chief Financial Officer. Graney will …

Appointment
spotleukaemia

Spotting Leukaemia

September 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025